Create issue ticket

30 Possible Causes for HEMATOPORPHYRIN, PHOTOCHEMOTHER

  • Giant Cell Glioblastoma

    Derivative Phase 3 32 Hematoporphyrins Phase 3 33 Antimitotic Agents Phase 3,Phase 1,Phase 2 34 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1,Early Phase 1 35[malacards.org] Phase 2,Phase 1 27 O(6)-benzylguanine Phase 3,Phase 2,Phase 1,Not Applicable 28 Anesthetics Phase 3 29 Anesthetics, General Phase 3 30 Anesthetics, Inhalation Phase 3 31 Hematoporphyrin[malacards.org]

    Missing: PHOTOCHEMOTHER
  • Calcitriol

    PURPOSE: To investigate the killing effect of photodynamic therapy (PDT) mediated by hematoporphyrin derivative (HPD) on human breast cancer MCF7 and MDA-MB-231 cells in vitro[ncbi.nlm.nih.gov]

    Missing: PHOTOCHEMOTHER
  • Carcinoma in Situ of the Bladder

    Abstract Whole bladder wall photoradiation therapy, using a hematoporphyrin derivative as a sensitizer, the red light (wavelength 630 plus or minus 1.6 nm.) of an argon dye[ncbi.nlm.nih.gov] A number of photo synthesizers have been used such as Hematoporphyrin derivatives and 5-aminolevulinic Acid (ALA).[intechopen.com]

    Missing: PHOTOCHEMOTHER
  • Gliosarcoma

    Derivative Phase 3 47 Hematoporphyrins Phase 3 48 Adjuvants, Anesthesia Phase 3 49 Analgesics Phase 3,Phase 2,Phase 1 50 Analgesics, Opioid Phase 3 Interventional clinical[malacards.org] Immunoglobulin G Phase 3,Phase 1,Phase 2 42 Mitogens Phase 3,Phase 1,Phase 2 43 Anesthetics Phase 3,Phase 1 44 Anesthetics, General Phase 3 45 Anesthetics, Inhalation Phase 3 46 Hematoporphyrin[malacards.org]

    Missing: PHOTOCHEMOTHER
  • Iris Melanoma

    Hematoporphyrin derivative was used as a sensitizing agent. The tumors were exposed to a total dose of 1.72 x 10(6) J/cm2 of 630-nanometer laser light.[ncbi.nlm.nih.gov]

    Missing: PHOTOCHEMOTHER
  • Onychomycosis

    Mycoses. 2017 Dec;60(12):830-835. doi: 10.1111/myc.12681. Epub 2017 Sep 6. Author information 1 2nd Department of Dermatology, Faculty of Medicine, Aristotle University, Papageorgiou General Hospital, Thessaloniki, Greece. 2 1st Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki,[…][ncbi.nlm.nih.gov]

    Missing: PHOTOCHEMOTHER
  • Rubeosis Iridis

    Packer JA, Tse DT, Gu X-Q, Hayreh SS: Hematoporphyrin photoradiation therapy for iris neovascularization. Arch Ophthalmol 1984;102:1193–1197.[karger.com]

    Missing: PHOTOCHEMOTHER
  • Cytotoxic Agent

    This very efficient singlet oxygen trap is not toxic to the cells nor does it absorb the light responsible for hematoporphyrin activation.[ncbi.nlm.nih.gov] We have found that the singlet oxygen-trapping product, o -dibenzoylbenzene, is formed nearly quantitatively intracellularly when both the furan and hematoporphyrin are present[cancerres.aacrjournals.org] […] oxygen, has been identified as the cytotoxic agent that is probably responsible for in vitro inactivation of TA-3 mouse mammary carcinoma cells following incorporation of hematoporphyrin[ncbi.nlm.nih.gov]

    Missing: PHOTOCHEMOTHER
  • Recurrent Respiratory Papillomatosis

    Photodynamic therapy with hematoporphyrin has been used effectively as . . .[nejm.org]

    Missing: PHOTOCHEMOTHER
  • Corneal Blood Staining

    […] overwhelms the keratocytes’ capacity to metabolize it, they undergo necrosis. 5 This observed cell death might be due to photosensitivity, as McDonnell et al found that hematoporphyrin[millennialeye.com] Frozen sections demonstrate fluorescence presumably corresponding to the hematoporphyrin derivative that is associated with toxicity.[missionforvisionusa.org]

    Missing: PHOTOCHEMOTHER

Further symptoms